Dr. Ishikawa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Cedar St
New Haven, CT 06510Phone+1 203-785-4162Fax+1 203-785-3826
Education & Training
Yale School of MedicinePost-Doctoral Fellowship, 2020
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2017 - 2020- Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 2014 - 2017
Hokkaido University Faculty of MedicineClass of 2007
Certifications & Licensure
CT State Medical License 2020 - 2025
NY State Medical License 2017 - 2021- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- A Nerve-Fibroblast Axis in Mammalian Lung Fibrosis.Genta Ishikawa, Xueyan Peng, John McGovern, Alexander Ghincea, Samuel Woo
Biorxiv. 2024-09-09 - Toll-like Receptor 9 Inhibition Mitigates Fibroproliferative Responses in Translational Models of Pulmonary Fibrosis.Glenda Trujillo, Alicia Regueiro-Ren, Chunjian Liu, Buqu Hu, Ying Sun
American Journal of Respiratory and Critical Care Medicine. 2024-08-27 - 2 citationsSingle-Cell Profiling Reveals Immune Aberrations in Progressive Idiopathic Pulmonary Fibrosis.Avraham Unterman, Amy Y Zhao, Nir Neumark, Jonas C Schupp, Farida Ahangari
American Journal of Respiratory and Critical Care Medicine. 2024-08-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
